1. |
Chiotan C, Radu L, Serban R, et al. Cytomegalovirus retinitis in HIV/AIDS patients[J]. J Med Life, 2014, 7(2): 237-240.
|
2. |
朱雪菲, 陆云峰, 陆培荣, 等. 白血病患者巨细胞病毒性视网膜炎的临床特点和疗效观察[J]. 中华眼底病杂志, 2018, 34(1): 43-46. DOI: 10.3760/cma.j.issn.1005-1015.2018.01.011.Zhu XF, Lu YF, Lu PY, et al. Clinical characteristics and treatment of cytomegalovirus retinitis in leukemia[J]. Chin J Ocul Fundus Dis, 2018, 34(1): 43-46. DOI: 10.3760/cma.j.issn.1005-1015.2018.01.011.
|
3. |
孙挥宇, 李丹, 毛菲菲, 等. 获得性免疫缺陷综合征合并巨细胞病毒性视网膜炎的特殊眼底病变特征[J]. 中华眼底病杂志, 2014, 30(3): 309-311. DOI: 10.3760/cma.j.issn.1005-1015.2014.03.020.Sun HY, Li D, Mao FF, et al. Characteristics of special fundus lesions in acquired immune deficiency syndrome with cytomegalovirus retinitis[J]. Chin J Ocul Fundus Dis, 2014, 30(3): 309-311. DOI: 10.3760/cma.j.issn.1005-1015.2014.03.020.
|
4. |
马楠, 叶俊杰, 李东辉, 等. 免疫重建炎症综合征的眼部病变[J]. 中华眼科杂志, 2014, 50(8): 593-597. DOI: 10.3760/cma.j.issn.0412-4081.2014.08.009.Ma N, Ye JJ, Li DH, et al. Ocular manifestations of immune reconstitution inflammatory syndrome[J]. Chin J Ophthalmol, 2014, 50(8): 593-597. DOI: 10.3760/cma.j.issn.0412-4081.2014.08.009.
|
5. |
Urban B, Bakunowicz-Łazarczyk A, Michalczuk M. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment[J/OL]. Mediators Inflamm, 2014, 2014: 971417[2014-06-24]. https://pubmed.ncbi.nlm.nih.gov/25089078/.DOI: 10.1155/2014/971417.
|
6. |
Yeo TH, Yeo TK, Wong EP, et al. Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore[J/OL]. J Ophthalmic Inflamm Infect, 2016, 6(1): 41[2016-11-07]. https://pubmed.ncbi.nlm.nih.gov/27822743/.DOI: 10.1186/s12348-016-0110-3.
|
7. |
Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis[J]. Ophthalmology, 1985, 92(4): 467-471. DOI: 10.1016/s0161-6420(85)34001-0.
|
8. |
Nguyen QD, Kempen JH, Bolton SG, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy[J]. Am J Ophthalmol, 2000, 129(5): 634-639. DOI: 10.1016/s0002-9394(00)00356-1.
|
9. |
Henderson HW, Mitchell SM. Treatment of immune recovery vitritis with local steroids[J]. Br J Ophthalmol, 1999, 83(5): 540-545. DOI: 10.1136/bjo.83.5.540.
|
10. |
Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis[J]. Am J Ophthalmol, 1998, 125(3): 292-300. DOI: 10.1016/s0002-9394(99)80134-2.
|
11. |
Karavellas MP, Lowder CY, Macdonald C, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome[J]. Arch Ophthalmol, 1998, 116(2): 169-175. DOI: 10.1001/archopht.116.2.169.
|
12. |
Wang B, Tian B, Tao Y, et al. Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis[J]. J Ocul Pharmacol Ther, 2014, 30(7): 587-592. DOI: 10.1089/jop.2013.0241.
|
13. |
余盈盈, 赵明威, 苗恒. 基于房水病毒学和炎性细胞因子检测的巨细胞病毒性视网膜炎治疗模式的初步研究[J]. 中华眼底病杂志, 2020, 36(1): 1-4. DOI: 10.3760/cma.j.issn.1005-1015.2020.01.001.Yu YY, Zhao MW, Miao H. Regime for cytomegalovirus retinitis based on aqueous virology and inflammatory cytokine determination[J]. Chin J Ocul Fundus Dis, 2020, 36(1): 1-4. DOI: 10.3760/cma.j.issn.1005-1015.2020.01.001.
|